User:Libby EMAcomm/Working page 2019
Here are my edits, please comment:
Fenspiride: Added link to EMA page on withdrawal of fenspiride medicines
Fenspiride: 04/10 Edited EMA reference to remove web editor's name
Omega-3 fatty acid: 04/10 Added summary of EMA review
Ulipristal acetate: 04/10 updated with final outcome of EMA review
Radium-223: 04/10 updated with summary of EMA Art 20 review
Hydroxyethyl starch: 04/10 updated with final outcome of Art 107i review
Daclizumab: 04/10 updated with information that the medicine was withdrawn
Dolutegravir: 16/10 updated with sentence on pregnancy contraindication in EU
Valproate: 16/10 added outcome of EMA 2018 review in pregnancy section
Quinolone antibiotic: 02/12 added outcome of EMA review in Other section
Cinoxacin: 02/12 added info that the MA suspended
Flumequine: 02/12 added info that the MA suspended
Nalidixic acid: 02/12 added info that the MA suspended
Pipemidic acid: 02/12 added info that the MA suspended
SGLT2 inhibitor: 02/12 /* Adverse effects */ Published outcome of EU review on risk of lower limb amputation